Thermal Induction and Temperature Control in the Hyperthermic Antiblastic Regional Perfusion with Extra Corporeal Circulation
An optimal treatment temperature choice is based on a compromise between the higher values desirable for best synergic effects between heat and drugs and the lower values required to avoid drug inactivation and tissue damage. Temperature uniformity throughout the limb under treatment favors approaching the highest temperature compatible with the above compromise. Several modifications have been introduced in the methodology during our experience consisting of more than 100 perfusions. The induction of true hyperthermic temperatures (41.5–41.8 °C) is achieved both heating the perfusate and directly heating the limb by means of a warm-water circulation blanket, thus insuring an optimal thermal flow to the superficial tissues. Devices in the extra-corporeal circuit have also been adopted to obtain a fast and accurate perfusate temperature control. The following results can be obtained: (a) a short delay time is required to reach the therapeutic temperature range; (b) the perfusate temperature is maintained at a value close to 40 ±0.5 °C during the whole hyper-thermic phase of the treatment; (c) the various districts of the limb are maintained at substantially homogeneous hyperthermic temperature.
KeywordsThermal Inactivation Regional Perfusion Short Delay Time Extra Corporeal Circulation Thermal Induction
Unable to display preview. Download preview PDF.
- 2.Hahn G.H.: “Hyperthermia and Cancer”, G.H. Hahn Ed., Plenum Press, New York, 1982;Google Scholar
- 4.Stehlin J.S. jr., Giovanella B.C., De Ipolyi P.D., Muenz L.R., Anderson R.F.: “Results of hyperthermic perfusion for melanoma of the extremities”, Surg. Gynec. Obstet. 140, 339–348, 1975;Google Scholar
- 5.Natali P.G., Zupi G., Greco C., Cavaliere R., Giacomini P., Ferrone S,: “Effect of Hyperthermia and neoplastic drugs on cell survival and antigenic profile of two human cell lines”, Proc. of 13th Intern. Congress of Chemotherapy, H.Khspitzy and K.Karrer Eds., Verlag Egerman H. A/1170, pp. 246/9–246/12, Wien 1983;Google Scholar
- 8.Krementz E.T., Carter R.D., Sutherland C.M., Muchmore J.H.: “Chemotherapy by regional perfusion for limb melanoma”, Ann. Surgeon, 53, 133–140, 1987;Google Scholar
- 9.Kroon B.B.R.: “Regional isolation perfusion in melanoma of the limbs: accomplishments, unsolved problems, future”, Eur. J. Surg. Oncology, 14, 101–110, 1988;Google Scholar
- 10.Krige J.E.J., King H.S., Stover R.M.: “Prophylactic Hyperthermic limb perfusion in stage I melanoma”, Eur. J. Surg. Oncology, 14, 321–326, 1988;Google Scholar
- 11.Pace M., Filomena A., Manetti R., Galli A., Macera Mascitelli E.: “Perfusione regionale ipertermico-antiblastica in circolazione extracorporea nei melanomi degli arti: indicazioni e tecnica”, Arch. Atti Soc. It. Chir., 90° Congr., vol. I, pp. 367–383, Roma (Italy) 1988;Google Scholar
- 12.Pace M., Filomena A., Manetti R., Galli A., Macera Mascitelli E.: “Improvements in the technique of isolated regional perfusion for melanoma of the extremities”, XXVI World Congress of the Intern. College of Surg., Vol. VIII, pp. 265–269, Milan (Italy) 1988;Google Scholar